Aptadel Therapeutics is a pre-clinical biomedical company.
Aptadel Therapeutics has raised $2.3M in total funding. The most recent round was Seed. The last funding was announced in March 2026.
Aptadel Therapeutics's investors include Little Warrior Foundation, Alba Pérez Foundation, Newsight Tech Angels.
Aptadel Therapeutics is headquartered in Barcelona, Spain.
Aptadel Therapeutics is a pre-clinical biomedical company.
Aptadel Therapeutics is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Aptadel Therapeutics — Funding & Investors." VCBacked, March 24, 2026, https://www.vcbacked.co/company/aptadel-therapeutics. Accessed July 19, 2026.
VCBacked. (2026). Aptadel Therapeutics — Funding & Investors. Retrieved July 19, 2026, from https://www.vcbacked.co/company/aptadel-therapeutics
{{cite web |title=Aptadel Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/aptadel-therapeutics |website=VCBacked |access-date=July 19, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated